Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Galiellalactone inhibits stem cell-like ALDH-positive prostate cancer cells.

Hellsten R, Johansson M, Dahlman A, Sterner O, Bjartell A.

PLoS One. 2011;6(7):e22118. doi: 10.1371/journal.pone.0022118. Epub 2011 Jul 11.

2.

C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.

Lim YC, Kang HJ, Moon JH.

Oral Oncol. 2014 Jul;50(7):633-9. doi: 10.1016/j.oraloncology.2014.04.004. Epub 2014 May 15. Review.

PMID:
24835851
3.

Evaluation and Isolation of Cancer Stem Cells Using ALDH Activity Assay.

Mele L, Liccardo D, Tirino V.

Methods Mol Biol. 2018;1692:43-48. doi: 10.1007/978-1-4939-7401-6_4. Review.

PMID:
28986885
4.

Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors.

Rodriguez-Torres M, Allan AL.

Clin Exp Metastasis. 2016 Jan;33(1):97-113. doi: 10.1007/s10585-015-9755-9. Epub 2015 Oct 7. Review.

5.

Disulfiram's Anticancer Activity: Evidence and Mechanisms.

Jiao Y, Hannafon BN, Ding WQ.

Anticancer Agents Med Chem. 2016;16(11):1378-1384. Review.

PMID:
27141876
6.

Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells.

Moreb JS, Ucar-Bilyeu DA, Khan A.

Cancer Chemother Pharmacol. 2017 Feb;79(2):295-301. doi: 10.1007/s00280-016-3213-5. Epub 2016 Dec 10. Review.

PMID:
27942929
7.

Reprogramming of prostate cancer cells--technical challenges.

Borges GT, VĂȘncio EF, VĂȘncio RZ, Vessella RL, Ware CB, Liu AY.

Curr Urol Rep. 2015 Jan;16(1):468. doi: 10.1007/s11934-014-0468-4. Review.

PMID:
25404182
8.

The cancer stem cell: premises, promises and challenges.

Clevers H.

Nat Med. 2011 Mar;17(3):313-9. doi: 10.1038/nm.2304. Review.

PMID:
21386835

Supplemental Content

Support Center